Multicenter cohort study reveals effective and safe ustekinumab treatment in ulcerative colitis, suggesting positive outcomes in Korean patients.
UST showed favorable 1-year effectiveness and an acceptable safety profile in Korean patients with UC.
No takes yet. Share an insight, caveat, or question.
Baek et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: